Objective Pre-eclampsia (PE) 
INTRODUCTION
Pre-eclampsia (PE) is associated with significant maternal morbidity and mortality and affects 5-7% of pregnant women worldwide. It is predominantly a disorder with cardiovascular manifestations, which is identified clinically by hypertension and proteinuria occurring after the 20 th week of gestation 1 . Recent evidence indicates that PE can be either early-onset (< 34 weeks' gestation) or late-onset (≥ 34 weeks' gestation) 2, 3 , suggesting that different pathophysiological mechanisms may contribute to the timing of onset of the condition 4 . PE is commonly associated with abnormal placental pathology and placenta-mediated complications, such as fetal growth restriction. Previous studies have shown that women with PE have an increased risk of developing cardiovascular disease in the future, the risk being much higher in those with early-onset and severe PE [5] [6] [7] . Recent investigations have also demonstrated that PE is associated with altered levels of angiogenic factors and abnormalities of cardiac function, namely impaired myocardial relaxation and diastolic dysfunction, which are more severe in early-onset PE 8 .
Cardiac myocytes release brain natriuretic peptide (BNP) and its inactive N-terminal fragment cleavage product, N-terminal pro-BNP, into the blood in response to stress. BNP level has been shown to be a sensitive marker for the detection of mild systolic or diastolic heart failure or of asymptomatic left ventricular (LV) dysfunction 9 , and for the diagnosis of congestive heart failure in patients with dyspnea in an acute-care setting. Although a few recent studies have suggested that BNP levels are elevated in pregnancy and in PE, it is not known whether this biochemical response is non-specific or directly related to the degree of diastolic dysfunction seen in pregnancy and PE 10, 11 . The aim of this study was to assess and compare maternal LV structure and diastolic function and levels of BNP in women with early-onset PE vs those with late-onset PE.
METHODS
This was a prospective cross-sectional study carried out over a 3-year period from January 2009, at the antenatal clinic of the Department of Obstetrics and Gynaecology, Botucatu Medical School, Brazil. Approval was obtained from the local institutional review committee, and all women presenting with singleton pregnancy and PE were recruited after providing informed consent. Only women without comorbidities and who were not receiving medical treatment were asked to participate in the study.
PE was defined according to the International Society for the Study of Hypertension in Pregnancy (ISSHP) guidelines 12 . The PE group was divided into two subgroups: the early-onset PE group, which included women who developed PE before 34 gestational weeks, and the late-onset PE group, including those who developed PE at or after 34 gestational weeks 13 . Subjects were categorized as having severe PE according to the ISSHP guidelines 12 . The control group was recruited and matched for gestational age with the PE groups at the time of sampling, and included women who remained normotensive until the end of gestation.
Body mass index, systolic blood pressure and diastolic blood pressure were measured and a physical examination was performed. Maternal blood pressure was measured manually at the brachial artery using a mercury sphygmomanometer according to the ISSHP guidelines 12 .
Brain natriuretic peptide measurement
Blood samples (10 mL) were collected according to a standardized method, without using a tourniquet, at the time of the echocardiographic examinations. All samples were centrifuged twice, immediately after collection, at 2000 rpm (112 g) to separate the plasma. Specimens were stored at -80 o C until analysis. BNP was measured using an enzyme-linked immunosorbent assay method (Wuhan EIAab, Science, China; cat no. E0541h). The limit of detection for the BNP method was 3.90 pg/mL; intra-and interassay precision was < 10% and < 15%, respectively.
Echocardiography
Ultrasound examinations were performed using a GE Vivid S6 machine (General Electric, Horten, Norway) by one expert investigator (S.G.Z.). Two-dimensional, M-mode and Doppler echocardiography was performed according to the guidelines of the American Society of Echocardiography and images were stored digitally 14 . Standard echocardiographic measurements included LV end-diastolic diameter (LVDd), end-diastolic wall thickness of the interventricular septum diameter (IVSd) and LV posterior wall thickness (PWT). LV mass (LVM) was calculated according to the Devereux and Reichek formula. LVM index (LVMi) was calculated by indexation of LVM by height 2.7 . Relative wall thickness (RWT) was calculated according to the formula (RWT) = ((IVSd + PWT)/2)/LVDd. LV hypertrophy was defined as LVMi ≥ 45 g/m 2.7 , considered concentric hypertrophy when RWT > 0.42 and eccentric hypertrophy when RWT < 0.42 15 .Transmitral, pulmonary venous flow velocities were acquired using pulsed Doppler. Early transmitral diastolic flow velocity (E) and flow velocity during atrial contraction (A), their ratio (E/A), and deceleration and isovolumic relaxation time were measured. Diastolic dysfunction was defined as E/A < 1.0 and/or isovolumic relaxation time > 100 ms and deceleration > 180 cm/s). Doppler indices were measured on three to five consecutive cardiac cycles and were averaged.
Statistical analysis
Data were analyzed using INSTAT software (GraphPad, San Diego, CA, USA). All variables were compared using the Kruskal-Wallis test, followed by Dunn's multiple comparison test, except for birth weight for which ANOVA was used. The Spearman rank order correlation coefficient was used to measure the association between some of the variables. P < 0.05 was considered statistically significant. We calculated that a sample size of 28 in each PE subgroup would be required in order to observe a 75% difference in the SD of BNP between PE cases and controls. A significance level of 5% (α = 0.05) and a statistical power of 80% (β = 0.20) were used.
RESULTS
The study group consisted of 30 women with early-onset PE, 32 with late-onset PE and 23 normotensive women (controls). Demographic and clinical characteristics of the study participants are shown in Table 1 . There was no difference in maternal age or body mass index among the groups. Women with early-onset PE had significantly higher systolic and diastolic blood pressure than those with late-onset PE (P = 0.05).
The results of echocardiographic geometric patterns and diastolic function are presented in Table 2 . Compared to women with late-onset PE, women with early-onset PE had increased median RWT (0.43 vs 0.38) and higher prevalence of LV concentric hypertrophy (40% vs 16%) (both P < 0.05). No significant difference was observed in the prevalence of eccentric hypertrophy between women with late-onset and those with early-onset PE (31% vs 10%, P = 0.085). Seven (23%) women with early-onset PE and five (16%) with late-onset PE demonstrated diastolic dysfunction compared with none in the control group (P < 0.05). Other parameters of diastolic function did not differ among the groups.
There was a significant graded increase in median BNP levels among women in the control (43 pg/mL), late-onset PE (147 pg/mL) and early-onset PE (214 pg/mL) groups (P < 0.05; Figure 1) . A significant correlation of levels of BNP with RWT and with LVMi was observed in women with early-onset and those with late-onset PE (Table 3 , Figures 2, 3) .
DISCUSSION
The present study demonstrated that women with early-onset PE exhibit more severe cardiovascular impairment compared with those with late-onset PE and that the magnitude of cardiovascular dysfunction is correlated with a significant increase in plasma concentrations of BNP. A significant increase in left atrial diameter, RWT, LVMi and flow velocity during atrial contraction (A) was observed, as well as a lower E/A ratio and altered LV geometry, in both PE groups in comparison with normotensive women.
In normal pregnancy, LVMi increases without changes in the ratio of wall thickness to cavity dimensions, indicative of preload-mediated heart remodeling 15, 16 . PE involves a state of arterial vasoconstriction leading to an increased afterload, with high total vascular resistance 17 . The maternal heart responds to the acute and transient increase in afterload with a process of adaptation characterized by remodeling, and sometimes concentric hypertrophy, despite the brevity of exposure of the heart to hypertension 18, 19 . Previous studies have demonstrated that the increased LVM is accompanied by an increase in cardiac work, suggesting that heart remodeling in PE is a response to the increased systemic afterload in order to minimize myocardial oxygen demand and thus preserve LV performance 20 . Valensise et al. 3 compared maternal cardiac function in a group of normotensive asymptomatic patients at 24 weeks' gestation with cardiac function in those who subsequently developed early-or late-onset PE. In this study, pregnant women with early-onset PE showed increased RWT and smaller LV diameter compared with the control and late-onset PE groups. These results demonstrated concentric hypertrophy, suggesting significant pressure overload in early-onset PE. Conversely, late-onset PE showed greater LV diameter, with an intermediate value of the left RWT compared with the early-onset PE and control groups, featuring eccentric hypertrophy, characteristic of volume overload [20] [21] [22] . A recent study found progression towards severe LV hypertrophy in association with advanced cardiac dysfunction in about 20% of women with preterm PE. This indicates that, although most women with PE undergo adaptive heart remodeling to increased afterload, a small subgroup demonstrate signs of overt decompensation 23 . Our echocardiographic findings are consistent with those of Valensise et al. 3 and Melchiorre et al. 23 . Women with PE had a higher incidence of concentric hypertrophy, especially those with early-onset PE (40%). The relevance of this result is the evidence that concentric LV hypertrophy is a risk marker for diastolic dysfunction, the abnormal accumulation of interstitial collagen in the myocardium and reduced coronary reserve. Our study did not include an assessment of coronary flow reserve or composition of the myocardium, but the echocardiographic examinations showed that women with early-onset PE and associated concentric hypertrophy had diastolic dysfunction, suggesting potential damage to the myocardium. The mechanism of dysfunction cannot be understood completely based on the results obtained. However, it is possible that the ventricles of small cavities and thick walls are less compliant. Thus, normal or even reduced blood volumes could result in increased filling pressure, characterizing diastolic dysfunction. Cardiac dysfunction can be associated with an increased concentration of natriuretic peptides, as these neurohormones are produced by the heart in cases of cardiac overload 24 . Currently, the clinical use of natriuretic peptides for diagnosis and risk stratification of heart failure is well established 25 ; however, there are conflicting results with regard to BNP levels during pregnancy 26, 27 . In our study, women with early-onset PE showed significantly higher BNP levels than those with late-onset PE and normotensive women. BNP levels were also higher in the late-onset PE group compared with controls. Furthermore, 97% of pregnant women with early-onset PE and 84.3% of women with late-onset PE showed mean concentrations of BNP above 100 pg/mL, which is considered a threshold for the diagnosis of dyspnea of cardiac etiology in non-pregnant women. Natriuretic peptides are recognized in non-pregnant individuals as markers of myocardial hypertrophy associated with cardiac dysfunction. Our study found a strong positive correlation between the concentration of BNP, LVMi and RWT in women with PE.
Our study had some limitations. Apart from the small numbers and its cross-sectional nature, it should also be noted that values of BNP have been variable in previous pregnancy studies. For example, in our study, the average value of BNP in normal pregnancy (43 pg/mL) was higher than that reported in other studies (20 pg/dL). These results can be explained by the recognized differences in both population and assay techniques.
In conclusion, the increased BNP levels in women with PE confirm that the observed maternal echocardiographic indices represent overt maternal diastolic dysfunction rather than an extended physiological adaptation to pregnancy. Furthermore, early-onset PE is characterized by an increased prevalence of concentric hypertrophy and LV diastolic dysfunction and higher BNP levels compared with late-onset PE, suggesting that this entity causes greater myocardial damage, increasing the risk of peripartum and postpartum cardiovascular sequelae. Although these cardiovascular effects are easily identified by echocardiographic parameters and a high plasma concentration of BNP, further studies are needed to assess the clinical utility of such measures.
